Navigation Links
Cellulosic Biofuels Leader Qteros Adds Key Positions
Date:10/24/2009

programs. From 1996 through 2007, Mr. McLaughlin was with PRAECIS Pharmaceuticals, where as the company's first Chief Financial Officer he had responsibility for private financings, partnership financings, and the company's IPO and secondary stock offerings. In 2004, Mr. McLaughlin became COO and then President and CEO and member of the Board of Directors of PRAECIS and was responsible for negotiations resulting in the sale of the company to GlaxoSmithKline. Earlier in his career he spent 16 years in senior financial roles at Prime Computer and Computervision Corporation.

"Qteros is a fast-moving company with a solid foundation and a great deal of promise in a next-generation industry," said Mr. McLaughlin. "It's very exciting to join the company as it prepares for significant growth."

Mr. Lerner was most recently Vice President of Ventures and Business support for BP's chemicals business based in Shanghai, China, where he served on the Board of Directors and represented BP's shareholder interests in a large joint venture located outside of Shanghai. Prior to that role, he was based in the Chicago area, as general manager of a $600 million global chemical business with manufacturing facilities in the U.S., Canada, and Europe. Earlier in his career, he served as Vice President of Ventures and Development for BP Chemicals based in Hong Kong and Venture Development Manager for Amoco Corporation, as well as holding positions in finance and engineering.

"Throughout my career, I've led multi-functional teams that were focused on creating value through developing and implementing new strategies, projects, and commercial arrangements -- in businesses with a commodity focus and a global perspective," Lerner said. "Bringing that experience to Qteros, a cutting-edge energy company with national and international ties, allows me to apply my skills in one of today's most exciting industries."

Qteros is
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
2. POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
3. Solazyme Testing BlueFire Ethanol Cellulosic Sugars in Its Microalgae Renewable Oil Production Process
4. Research Reinforces Economic, Environmental Benefits of Corn Cobs as Source for Cellulosic Ethanol
5. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
6. Verenium Announces First Commercial Cellulosic Ethanol Project
7. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
8. Dartmouth researchers advance cellulosic ethanol production
9. POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year
10. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
11. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cellulosic Biofuels Leader Qteros Adds Key Positions 
(Date:8/3/2015)... , Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... focused on the development of autologous cell therapies, announced today ... at the InvestMNT conference held in Minneapolis, Minnesota ... local time. Hall,s presentation will highlight RepliCel,s 18-month milestones including ... Europe , clinical data from both RCT-01 ...
(Date:7/31/2015)... HONG KONG , July 31, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... with the U.S. Securities and Exchange Commission. The filed ... year ended March 31, 2015. The Form 20-F can ...
(Date:7/30/2015)...   GenoSpace , a leading provider of ... of genomic and other biomedical data, today announced ... company as Vice President of Sales and Marketing. ... "GenoSpace partners with its customers to ... explore complex sets of genomic, phenotypic and other ...
(Date:7/30/2015)... Diego , CA (PRWEB) , ... July 30, ... ... announced the successful completion of a field clinical study of its canine osteoarthritis ... developed together with Aratana Therapeutics (Kansas City, KS) and will be marketed in ...
Breaking Biology Technology:RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2China Cord Blood Corporation Files Its Annual Report on Form 20-F 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3
... Cell Therapeutics, Inc. ("the Company") (Nasdaq and MTA: CTIC) ... up results from the Company,s pivotal phase III PIX301 ... recent Marketing Authorization Application (the "MAA") currently under review ... end-of-study results showed continued improvement in the trial,s primary ...
... 2010 Gentiva Health Services, Inc. (Nasdaq: ... and hospice services, announced today that it has scheduled a ... 10:00 a.m. ET to provide an update on its 2011 ... of December 16 before pre-market trading. The December ...
... 3, 2010 Nu Skin (NYSE: NUS ... physical vitality is improved through nutritional strategies that influence ... the First World Congress on Targeting Mitochondria: Strategies, Innovation ... Nu Skin,s innovative ageLOC science we have successfully identified ...
Cached Biology Technology:New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 2New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 3New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 4New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 5New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 6Gentiva® Health Services Schedules 2011 Outlook Conference Call and Webcast for Thursday, December 16, 2010 2Gentiva® Health Services Schedules 2011 Outlook Conference Call and Webcast for Thursday, December 16, 2010 3Nu Skin Scientists Present ageLOC Research at International Conference on Mitochondria 2Nu Skin Scientists Present ageLOC Research at International Conference on Mitochondria 3
(Date:7/21/2015)... Passwords have proven futile for securing ... U.S. Office of Personnel Management breach. Biometric authentication ... but developers and end-users are concerned about how ... Biometrics-as-a-Service provider HYPR Corp. announced today the general ... party integration. A video overview ...
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/9/2015)... Calif. , July 9, 2015  Unchained ... today announcing its acquisition of Avid Nano. Avid ... light scattering (DLS) systems.    Also ... smallest, fastest and easiest to use protein sizing ... that measures a protein,s hydrodynamic size, size distribution, ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... has found that the red squirrel population along the ... outbreak of squirrelpox in 2008. Researchers from the ... been monitoring the red squirrel population at the Seaforth ... 85% fall in the red squirrel population. Squirrel ...
... STOCKHOLM , November 26, 2013 ... et en extérieur dans plus de 30 pays ... en Suède, vient de lancer Trax, un traceur GPS ... appareil intelligent et son application permettent aux utilisateurs de ...
... Barbara, Calif.) Sepsis, the body,s response to severe ... and HIV/AIDS combined. On average, 30 percent of those ... by Jamey Marth, director of UC Santa Barbara,s Center ... Institute, reports a new method to increase survival in ...
Cached Biology News:Red Squirrels showing resistance to squirrelpox 2Suivez vos enfants et vos animaux domestiques grâce à TRAX, le nouveau traceur GPS intelligent 2Suivez vos enfants et vos animaux domestiques grâce à TRAX, le nouveau traceur GPS intelligent 3UCSB biomedical scientist discovers a new method to increase survival in sepsis 2UCSB biomedical scientist discovers a new method to increase survival in sepsis 3
S-100 alpha/beta chain (8B10)...
... a new product number, created to ... showing no availability yet, please order ... or contact customer service for assistance. ... mm, No. of sidearm 4 ...
... 15(S)-15-methyl PGF2α is a ... It is a potent uterine ... be administered intramuscularly to induce ... reduces serum progesterone concentrations when ...
TGase3 (S-20)...
Biology Products: